Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Παρόμοια τεκμήρια

• Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”
  από: Chung-Feng Huang, κ.ά.
  Έκδοση: (2024-10-01)
• Impact of all-oral direct-acting antivirals on hepatocellular carcinoma in Vietnamese patients with chronic HCV genotype 1
  από: Thong D Vo, κ.ά.
  Έκδοση: (2025-10-01)
• Clinicoepidemiologic Study of Hepatocellular Carcinoma among HCV Induced Compensated Cirrhotic Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Drugs.
  από: Dina Abdallah, κ.ά.
  Έκδοση: (2024-06-01)
• Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
  από: Chen-Ta Chi, κ.ά.
  Έκδοση: (2021-06-01)
• Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
  από: Chung-Feng Huang, κ.ά.
  Έκδοση: (2025-01-01)